Review of Heavy Ion Accelerators for Hadrontherapy

Size: px
Start display at page:

Download "Review of Heavy Ion Accelerators for Hadrontherapy"

Transcription

1 Review of Heavy Ion Accelerators for Hadrontherapy Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences 11 th Int l Conf. on Heavy Ion Accelerator Technology, June 1 9, Venice, Italy

2 1. Introduction Contents 2. Heavy-Ion Cancer Therapy Facility Asia Europe 3. New Project at 4. Summary

3 Introduction Feature of Ion Radiotherapy Good longitudinal dose localization due to the Bragg peak. 5 4 Lateral biological dose distribution C proton Relative dose (%) Dose (GyE) lateral position (cm) Depth in water (cm) C ion n gamma-ray proton Good transverse dose localization due to the low scattering.

4 Biological Effect of Ion beams Introduction RBE, OER H RBE OER C Si LET LET (kev/μ) (kev/μm) LET dependence on RBE, OER LET Dependence of RBE & OER Biological Dose (GyE) Biological Dose (GyE) Biological Biological Depth-Dose Distribution of 6cm of SOBP 6cm SOBP He C Ne Tumor Normal tissue Proton Depth in Water Depth in Water

5 Pioneering Work at LBL Introduction Bevalac J. Castro June 75: 1 st He patient May 77: 1 st C patient Nov. 77: 1 st Ne patient Mar. 79: 1 st Ar patient Nov. 82: 1 st Si patient Total: He patients 858 Heavier ions 456

6 1. Introduction Contents 2. Heavy-Ion Cancer Therapy Facility Asia Europe 3. New Project at 4. Summary

7 HI Facility facility Ion species: High LET (1keV/μm) charged particles He, C, Ne, Si, Ar Range: 3cm in soft tissue 8MeV/u (Si) Maximum irradiation area: 22cmΦ Eye Dose rate: 5Gy/min Lachrymal Head & Neck Beam direction: horizontal, vertical Digestive duct Lung Liver Brain Bone & Soft tissue Pancreas Tumors Rectum Prostate Uterus More than 4,5 pts treated since pts/y, 7 d/y (Heavy Ion Medical Accelerator in Chiba)

8 Present Method HI Facility Broad Beam Method with Wobbler and Scatterer Dose distribution is independent of beam quality Easy dose management Low beam-utilization efficiency Extra-dose is given on normal tissue when irregular shape Require Bolus and patient collimator

9 Hyogo Facility HI Facility 1) Proton: Energy: 23 MeV 2 Gantry + 1 H 2) Carbon Energy: 32 MeV/n 1 H&V, 45º line 1GHz-ECR IS: 2 2MHz RFQ+DTL: 5MeV/n Synchrotron(96m) Multiturn Injection RF-KO extraction 2,339 pts treated from May 1 to Oct 8

10 Design and R&D by NIRS HI Facility Beam Study Compact RF-cavity Compact Injector RFQ + APF-IH Development Irrad. Tech. Intensity (1 1 ppp) Intensity (1 1 ppp) Veritcal tune Vertical tune High-Precision MLC

11 Gunma University HI Facility Treatment room Synchrotron Carbon: Energy: 14-4 MeV/n H&V, H, V and R&D room 1GHz-ECR IS 2MHz RFQ+APF-IH:.6 4MeV/n Synchrotron(~62m) Multiturn Injection RF-KO extraction Acc. Driven extraction 1GHz-ECR Spiral Wobbling Respiratory-Gated Irrad. RFQ+APF-IH Linac Layer-stacking Irrad.

12 T1 NIRS IMP at Lanzhou, China HI Facility SSC PDC Surface tumor 1MeV/n C K=4 TR1 TL1 TL2 TR2 TR4 TR3 HIRFL SFC 5 K=69 RIBLL2 9.4 Tm 5MeV/u U 92+ (128.8 m) Deeply seated tumor 43MeV/n C Cooler-Synchrotron TR5 RIBLL Tm (161m) PT 1.1GeV/u C Gev--p Injector: SFC Cooler Synchro Charge Ex. Inj. Cool Stacking

13 The Heidelberg Ion Therapy Centre HIT Facility p, He, C, O: Energy: 5-43 MeV 1 Gantry + 2 H HI Facility ECR IS: 2 216MHz RFQ+IH: 7MeV/n Synchrotron(~6m) Multiturn Injection RF-KO extraction Based on GSI treatments of 4pts since 97, HIT has been constructed. Variable Energy Operation Variable FT (1-1s) Variable Intensity Variable Beam Size

14 Raster Scanning Developed by GSI HI Facility Variable Energy Operation Variable Intensity Variable Beam Size

15 HI Facility Revised HIT Accelerator Design by Siemens The HIT accelerator design has been modified To improve technical capabilities To reduce const ruction and operating costs Examples 1) 12dipoles(each8tons) instead of 6(each25tons) cost reduction,easier installation and handling 2) Smaller and lighter quadrupoles cost reduction,less power consumption 3) Optimized injection and extraction system Higher intensity,shorter treatment times 4) 3sources more flexibility,other ions species

16 HI Facility New Projects by Siemens Marburg Kiel

17 HI Facility CNAO Facility Synchrotron for light ions (z 6) Active scanning Range 27 g/cm 2 3 treatment rooms Space for 2 gantries p, He, C, O: Energy: p 7-25 MeV C 7-4 MeV/n 2 H + H&V Injector: GSI design Synchrotron: PIMMS design ECR IS: 2 216MHz RFQ+IH: 7MeV/n Synchrotron(~78m) Multiturn Injection Acc Driven extraction RF-KO extraction Active scan

18 1. Introduction Contents 2. Heavy-Ion Cancer Therapy Facility Asia Europe 3. New Project at 4. Summary

19 Motivation of New Treatment Facility New Project (a) (b) 84cc 69cc Large changing target shape and size We should modify a treatment planning corresponding to change of target during treatment, Adaptive Cancer Treatment

20 3D Scanning Method New Project Adaptive Therapy by 3D Scanning 1) Beam utilization efficiency 1% 2) Irradiation on irregular shape target 3) No bolus & collimator 1) Depend directly on beam quality 2) Not easy dose management 3) Sensitive to organ motion Scanner Monitor Range Shifter Beam Dose distribution of pencil beam

21 3D organ motion with breathing New Project

22 -4-2 NIRS Simulation of moving tumor irradiation Non-gating Example: Φ4mm spherical target Motion:7mm in gate ( πt / 3, φ ) s( t) = cos 2s 4-4 Gating Moving Tumor Irradiation New Project Gating with rescanning (8 times) In order to avoid hot/cold spot due to target motion, we decided to employ gating method with rescanning

23 -4-2 NIRS Simulation of moving tumor irradiation Non-gating Example: Φ4mm spherical target Motion:7mm in gate -4 Gating Moving Tumor Irradiation Fast Scanning is the key technology for completing rescanning within tolerable time. ( πt / 3, φ ) s( t) = cos 2s New Project Gating with rescanning (8 times) In order to avoid hot/cold spot due to target motion, we decided to employ gating method with rescanning

24 New Project Fast scanning for moving target In order to realize the rescanning with gating within acceptable irradiation time, we have studied following strategy. 1. Treatment planning for fast scanning 5 2. Modification of acc. operation 2 3. Fast scanning magnet 1 1-times speed up of irradiation time

25 (1) Planning for fast scanning Optimization including the contribution of extra dose in raster scanning New Project Without U i.5 Ui Beam intensity y (m m ) -5 5 Fast scanning with beam of high intensity EDR cause dose distortion -5-5 x (m m ) 5 f Cost function : f(w) ( ) o w = Q D ( w) i T P max 2 u min 2 [ ] [ ( )] max biol, i + U i DP + Q + [ ( ) + ] + P DP U i Dbiol, i w + + QO Dbiol, i w U i DO i O 2 + Predict EDR With U i Extra dose in raster scanning (EDR) : U i 5

26 New Project 42 s (2) Extended FT in Synchrotron Normal Ope Extended FT Ope Since c-ions is enough high to complete single-fraction, we have employed the extended FT to save the dead time of synchrotron operation. Irrad Slice Change Irrad 2 s 1. Treatment planning for fast scanning 5 2. Modification of acc. operation 2 3. Fast scanning magnet 1

27 New Project (3) Fast Scanning Magnet 1mm/ms in H 5mm/ms in V Scanning Magnet Pos. Moni. Dose Moni Range Shifter Since 29 December 28

28 Fast 3D-Scanning Experiment New Project (1)+(2) Total time: Scanning time: Range-shifter time: 76 s 64 s 12 s (1)+(2)+(3) Total time: 18.5 s Scanning time: 6. 5 s Range-shifter time:12 s

29 New Treatment Facility (1) New Project 3D Scanning with Gating (H&V): 2 rooms Rotating Gantry : 1 room Research Building for Charged Particle Therapy building Hospital New treatment facility Rotating Gantry Wall RGF QM PRN1 SMx SMy PRN2 RSF 3D Scanning 9. m Monitors 1 2m Iso-center

30 New Project New Treatment Facility (2) Ground-Breaking Ceremony Construction 19 Feb, 9 6 Feb, 9

31 New Treatment Facility (3) New Project The construction of the new treatment facility will be completed at March 21. New facility building

32 1. Introduction Contents 2. Heavy-Ion Cancer Therapy Facility Asia Europe 3. New Project at 4. Summary

33 2) In Europe HIT facility has completed the full beam commissioning and will start the treatment of 1 st patient soon. CNAO facility has been being constructed, and the beam commissioning of the injector has been being carried out. Siemens has constructed Marburg and Kiel facilities and made a contract with Shanghai project Lyon and Med-Austron projects will start the construction ARCHADE and INF projects have designed superconducting cyclotron. NIRS Summary 1) In Asia, Hyogo and IMP facilities have been well going on hadrontherapy Saga and Kanagawa prefectures just approved the facility construction. China has several plans of the hadrontherapy facility Taiwa also is preparing

34 Heavy Io Therapy in the World Introduction Kiel Marlburg Darmstadt MedAustron Lanzhou HIT Lyon CNAO Gunma Thanks for your attention!! Chiba LBL Hyogo Carbon Carbon (under construction) Carbon (Approved planning) Carbon (Shutdown) XXX : has an official collaboration with NIRS

New Treatment Research Facility Project at HIMAC

New Treatment Research Facility Project at HIMAC New Treatment Research Facility Project at Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences IPAC10, Kyoto, JAPAN, 25th May, 2010 Contents 1. Introduction

More information

Review of Hadron machines for cancer therapy

Review of Hadron machines for cancer therapy Review of Hadron machines for cancer therapy M. Kanazawa NIRS cancer therapy with hadron (p, C) Clinical studies at New ideas of accelerators Compact facilities (p, C) Depth dose distribution Carbon, proton

More information

Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy -

Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy - Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy - Takeshi Murakami Research Center of Charged Particle Therapy National Institute of Radiological Sciences 2012.11.21 1. Introduction to

More information

Summary of Synchrotron for Hadron Therapy

Summary of Synchrotron for Hadron Therapy Summary of Synchrotron for Hadron Therapy April 30, 09 Koji Noda 1. G.H. Rees ; A New Tracking Gantry-Synchrotron Idea 2. K. Noda ; Overview of NIRS Accelerator Activity 3. T. Haberer ; The Heidelberg

More information

Heavy Ion Tumor Therapy

Heavy Ion Tumor Therapy Heavy Ion Tumor Therapy Applications Bence Mitlasoczki 25.06.2018 Heidelberg 1. Source (H 2 /CO 2 ) 2. Linac 3. Synchrotron 4. Guide 5. Treatment rooms 6. X-ray system 7. Gantry 8. Treatment room with

More information

Progress of Heavy Ion Therapy

Progress of Heavy Ion Therapy Progress of Heavy Ion Therapy Fuminori Soga Division of Accelerator Physics and Engineering, National Institute of Radiological Sciences, 4-9-1 Anagawa. Inage-ku, Chiba 263-8555, Japan 1. Introduction

More information

The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center

The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center Thomas Haberer, Scientific Technical Director, Heidelberg Ion Therapy Center Situation / Indications 2/3 patients suffer

More information

Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC

Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC Radiation qualities in carbon-ion radiotherapy at NIRS/ Shunsuke YONAI Radiological Protection Section Research Center for Charged Particle Therapy National Institute of Radiological Sciences (NIRS) E-mail:

More information

SUMITOMO Particle Therapy Technologies

SUMITOMO Particle Therapy Technologies 55 th AAPM annual meeting Particle Beam Therapy Symposium SUMITOMO Particle Therapy Technologies August 3, 2013 Yukio Kumata Experience accelerators for science Current Status proton and carbon Future

More information

Nuclear Data for Radiation Therapy

Nuclear Data for Radiation Therapy Symposium on Nuclear Data 2004 Nov. 12, 2004 @ JAERI, Tokai Nuclear Data for Radiation Therapy ~from macroscopic to microscopic~ Naruhiro Matsufuji, Yuki Kase and Tatsuaki Kanai National Institute of Radiological

More information

III. Proton-therapytherapy. Rome SB - 5/5 1

III. Proton-therapytherapy. Rome SB - 5/5 1 Outline Introduction: an historical review I Applications in medical diagnostics Particle accelerators for medicine Applications in conventional radiation therapy II III IV Hadrontherapy, the frontier

More information

T.Kanai, K. Yusa, M. Tashiro, H. Shimada, K. Torikai, Gunma University, Gunma, Japan

T.Kanai, K. Yusa, M. Tashiro, H. Shimada, K. Torikai, Gunma University, Gunma, Japan The carbon-ion cancer therapy facility at Gunma University T.Kanai, K. Yusa, M. Tashiro, H. Shimada, K. Torikai, J. Koya, T. Ishii, Y. Yoshida, S. Yamada, T. Ohno, T. Nakano Gunma University, Gunma, Japan

More information

Ion Beam Therapy should we prioritise research on helium beams?

Ion Beam Therapy should we prioritise research on helium beams? Ion Beam Therapy should we prioritise research on helium beams? Stuart Green Medical Physics University Hospital Birmingham NHS Trust Follow-up from the EUCARD2 workshop, ION Beam Therapy: Clinical, Scientific

More information

Introduction to Ion Beam Cancer Therapy

Introduction to Ion Beam Cancer Therapy Introduction to Ion Beam Cancer Therapy Andrew M. Sessler (with some slides from David Robin) Lawrence Berkeley National Laboratory Berkeley, CA 94720 Cyclotron 10, Lanzhou September 10, 2010 Contents

More information

Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May

Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May IONTRIS Synchrotron based PT Solutions from Siemens AG Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May 1 2009 Matthias Herforth VP Business Development and Communications Siemens AG

More information

The Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009

The Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009 The Heidelberg Ion Therapy Center Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009 Goal The key element to improve the clinical outcome is local l control! entrance channel:

More information

The Heidelberg Ion Therapy (HIT) Accelerator Coming Into Operation. Presented at EPAC 2008, Genova D. Ondreka, GSI

The Heidelberg Ion Therapy (HIT) Accelerator Coming Into Operation. Presented at EPAC 2008, Genova D. Ondreka, GSI The Heidelberg Ion Therapy (HIT) Accelerator Coming Into Operation Presented at EPAC 2008, Genova D. Ondreka, GSI Introduction Heidelberg Ion Therapy Centre: Europe's first dedicated particle therapy facility

More information

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Supervisors Prof. V. Patera PhD R. Van Roermund Candidate Annalisa Patriarca

More information

The Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center

The Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center The Heidelberg Ion Therapy Center and PARTNER Thomas Haberer Heidelberg Ion Therapy Center Goal The key element to improve the clinical outcome is local control! entrance channel: low physical dose low

More information

Proton and heavy ion radiotherapy: Effect of LET

Proton and heavy ion radiotherapy: Effect of LET Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer

More information

PROGRESS IN HADRONTHERAPY

PROGRESS IN HADRONTHERAPY PROGRESS IN HADRONTHERAPY Saverio Braccini TERA Foundation for Oncological Hadrontherapy IPRD06 - Siena - 01.10.06 - SB 1 Outline Introduction Radiation therapy with X rays and hadrontherapy Hadrontherapy

More information

HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN

HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN S. Yamada, T. Honma, M. Kanazawa, A. Kitagawa, S. Kouda, M. Kumada, T. Murakami, M. Muramatsu, T. Nishio, K. Noda, Y. Sato, M. Suda and E. Takada, Research

More information

A review of cyclotrons for Hadron Therapy. Y. Jongen Cyclotrons 2010 Lanzhou, September

A review of cyclotrons for Hadron Therapy. Y. Jongen Cyclotrons 2010 Lanzhou, September A review of cyclotrons for Hadron Therapy Y. Jongen Cyclotrons 2010 Lanzhou, September 10 2010 The early days The possible use of the Bragg peak of high energy ions in the radiotherapy of cancer was suggested

More information

ACCELERATORS FOR HADRONTHERAPY

ACCELERATORS FOR HADRONTHERAPY ACCELERATORS FOR HADRONTHERAPY Alberto Degiovanni CERN-BE IVICFA s Fridays: Medical Physics Valencia, 31.10.2014 Introduction: the icon of hadrontherapy Position of the Bragg peak depends on beam energy

More information

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE I. Petrovi a, A. Risti -Fira a, L. Kori anac a, J. Požega a, F. Di Rosa b, P. Cirrone b and G. Cuttone

More information

Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034

Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034 Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034 Saudi-Japan Business Opportunities Forum February 1 2, 2012 1 2 Types of Treatment Conventional Radiation Therapy Uses photons (energetic

More information

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏 林口 Proton Therapy in Ti Taiwan *Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏 Chang Gung Memorial Hospital at Lin-Kou, Taiwan 林口長庚紀念醫院 OCPA2010 at Beijing, China Aug. 5, 2010 Outline 1. The principle of proton radiotherapy

More information

Status of Hadrontherapy facilities worldwide

Status of Hadrontherapy facilities worldwide Status of Hadrontherapy facilities worldwide Vienna 15.03.2011 The Gantry 1 of PSI Eros Pedroni Center for Proton Radiation Therapy Paul Scherrer Institute SWITZERLAND Author s competence: Gantry with

More information

SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY

SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY SAVERIO BRACCINI * Albert Einstein Centre for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Sidlerstrasse

More information

A brief presentation of The TERA Foundation

A brief presentation of The TERA Foundation A brief presentation of The TERA Foundation David Watts on behalf of Prof. Ugo Amaldi and all my colleagues at TERA TERA Overview Direction: Prof. Ugo Amaldi AQUA (Advanced QUAlity Assurance) Cyclinac

More information

Tumor Therapy with Heavy Ions at GSI Darmstadt

Tumor Therapy with Heavy Ions at GSI Darmstadt Tumor Therapy with Heavy Ions at GSI Darmstadt D. Schardt 1) for the Heavy Ion Therapy Collaboration 2) 1) Gesellschaft für Schwerionenforschung (GSI), Darmstadt, Germany 2) GSI Darmstadt / Radiologische

More information

An Introduction to Cancer Therapy With Hadron Radiation

An Introduction to Cancer Therapy With Hadron Radiation An Introduction to Cancer Therapy With Hadron Radiation Andrew M. Sessler Lawrence Berkeley National Laboratory Berkeley, CA 94720 April, 2008 Contents 1. History 2. X-Ray Machines 3. Why Hadrons? Which

More information

HEAVY PARTICLE THERAPY

HEAVY PARTICLE THERAPY HEAVY PARTICLE THERAPY DR. G.V. GIRI KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY ICRO 2012 BHATINDA HEAVY PARTICLES USED IN A EFFORT TO IMPROVE TUMOR CONTROL, THAT DO NOT RESPOND TO PHOTONS OR ELECTRONS BETTER

More information

PTCOG 46. Educational Workshop Session IV. Head & Neck CLINICAL. J. Mizoe (NIRS, Japan)

PTCOG 46. Educational Workshop Session IV. Head & Neck CLINICAL. J. Mizoe (NIRS, Japan) PTCOG 46 Educational Workshop Session IV CLINICAL Head & Neck J. Mizoe (NIRS, Japan) Photon X-Ray γ-ray Fast Neutron Non-Charged Radiation Electron Proton Helium Light Ion Heavy Particle Carbon Neon Argon

More information

IMPT with Carbon Ions

IMPT with Carbon Ions IMPT with Carbon Ions PTCOG 48, Heidelberg, 28.09.-03.10.2009 Malte Ellerbrock Medical Physics Expert Heidelberg Ion-Beam Therapy Center HIT Betriebs GmbH am Universitätsklinikum Heidelberg http://www.hit-centrum.de

More information

Biological Optimization of Hadrontherapy. Uwe Oelfke

Biological Optimization of Hadrontherapy. Uwe Oelfke 4/2/2012 page 1 Biological Optimization of Hadrontherapy Uwe Oelfke DKFZ Heidelberg (E040) Im Neuenheimer Feld 280 69120 Heidelberg, Germany u.oelfke@dkfz.de 4/2/2012 page 2 Contents Introduction and General

More information

Plans for the Precision Cancer Medicine Institute University of Oxford

Plans for the Precision Cancer Medicine Institute University of Oxford Plans for the Precision Cancer Medicine Institute University of Oxford STFC & Particle Accelerators and Beams group workshop on particle accelerators for medicine 17 th February 2015 Claire Timlin The

More information

Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center

Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center The Heidelberg Ion Beam Therapy Center A Hospital-based Facility Dedicated to Precision and Flexibility Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center Carbon Ion Therapy

More information

Present status and future of Proton beam therapy

Present status and future of Proton beam therapy Present status and future of Proton beam therapy Description At present, the types of proven treatment for cancer are surgery, radiotherapy, and chemotherapy. Depending on the characteristics of cancer

More information

ACCELERATOR DESIGN ISSUES IN CANCER THERAPY

ACCELERATOR DESIGN ISSUES IN CANCER THERAPY ACCELERATOR DESIGN ISSUES IN CANCER THERAPY December 25 P.J. Bryant CERN John ADAMS Memorial Lecture 25- P.J. Bryant - Slide 1 Contents Introduction Hadrons & voxel scanning Experimental setup A closer

More information

Heidelberg Ion-Beam Therapy Centre (HIT) officially opened

Heidelberg Ion-Beam Therapy Centre (HIT) officially opened Powered by Website address: https://www.gesundheitsindustrie-bw.de/en/article/pressrelease/heidelberg-ion-beam-therapy-centre-hit-officiallyopened/ Heidelberg Ion-Beam Therapy Centre (HIT) officially opened

More information

Basic Press Information

Basic Press Information Basic Press Information Contact MedAustron EBG MedAustron GmbH Marie Curie-Strasse 5 A-2700 Wiener Neustadt Austria T +43 2622 26 100-0 e-mail: office@medaustron.at Internet: www.medaustron.at Press contact:

More information

Activities at the Heidelberg Ion Therapy Center (HIT)

Activities at the Heidelberg Ion Therapy Center (HIT) Activities at the Heidelberg Ion Therapy Center (HIT) The people A. Mairani (now INFN), F. Sommerer (Uniklinikum Heidelberg), I. Rinaldi (DKFZ Heidelberg), K. Parodi (HIT and University of Heidelberg)

More information

OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY

OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY Abstract The CNAO (National Centre for Oncological Hadrontherapy) has been realized in Pavia. It is a clinical facility created and financed by the Italian

More information

CERN: from particle physics to medical applications. Manuela Cirilli CERN Knowledge Transfer Life Sciences Section

CERN: from particle physics to medical applications. Manuela Cirilli CERN Knowledge Transfer Life Sciences Section CERN: from particle physics to medical applications Manuela Cirilli CERN Knowledge Transfer Life Sciences Section The mission of CERN Research Innovation Push forward the frontiers of knowledge Develop

More information

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania Proton Treatment Keith Brown, Ph.D., CHP Associate Director, Radiation Safety University of Pennsylvania Proton Dose vs. Depth Wilson,. R.R. Radiological use of fast protons. Radiology 47:487-491, 1946.

More information

Particle Therapy- Why?

Particle Therapy- Why? Particle Therapy- Why? Kill tumour without affecting healthy cells X-Ray Therapy Head, neck, Spinal cord Eyes, orbits Pelvis Prostate Lung PEDIATRIC Proton Therapy Photon IMRT Photon Proton (Courtesy of

More information

Radiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada

Radiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada Overview Introduction Overview Introduction Brachytherapy Radioisotopes in contact with the tumor Overview

More information

Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon

Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon Introduction Why Particle Therapy? PT Milestones What is meant by Industrialization Examples Protons-only:

More information

ABSTRACTS. of the NIRS International Seminar on the Heavy Charged Particle Therapy for Cancer and the XXVII PTCOG MEETING.

ABSTRACTS. of the NIRS International Seminar on the Heavy Charged Particle Therapy for Cancer and the XXVII PTCOG MEETING. P ROTON THERAPY C O- OPERATIVE GROUP Chair Michael Goitein Ph. D. Department of Radiation Oncology Massachusetts General Hospital Boston MA 02114 (617) 724-9529 (617) 724-9532 Fax Secret ary Janet Sisterson

More information

MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, *

MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, * Radiation Protection Dosimetry (2009), Vol. 137, No. 1 2, pp. 156 166 Advance Access publication 14 October 2009 doi:10.1093/rpd/ncp192 MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, * 1

More information

REVIEW ON CYCLOTRONS FOR CANCER THERAPY

REVIEW ON CYCLOTRONS FOR CANCER THERAPY FRM1CIO01 Proceedings of CYCLOTRONS 2010, Lanzhou, China REVIEW ON CYCLOTRONS FOR CANCER THERAPY Yves Jongen#, IBA, Louvain-la-Neuve, Belgium Abstract The science and technology of proton and carbon therapy

More information

Heavy Ion Therapy: Status and Perspectives

Heavy Ion Therapy: Status and Perspectives Technology in Cancer Research & Treatment ISSN 1533-0346 Volume 2, Number 5, October (2003) Adenine Press (2003) Heavy Ion Therapy: Status and Perspectives www.tcrt.org Starting with the pioneering work

More information

Status of heavy-ion therapy at Institute of Modern Physics Chinese Academy of Sciences Guoqing Xiao. PTCOG ,Shanghai

Status of heavy-ion therapy at Institute of Modern Physics Chinese Academy of Sciences Guoqing Xiao. PTCOG ,Shanghai Status of heavy-ion therapy at Institute of Modern Physics Chinese Academy of Sciences Guoqing Xiao PTCOG53 2014.6.8-14,Shanghai Outline Carbon therapy researches at IMP Status of Heavy Ion Medical Machine

More information

Look! Borg get upgrade already!

Look! Borg get upgrade already! Cancer, Partikel Terapi and PT accelerators Look! Borg get upgrade already! 1 Cancer, Partikel Terapi and PT accelerators Basic requirements to PT accelerator Accelerators for PT Siemens PT maskinen Alternativer:

More information

Radiological Protection in Ion Beam Radiotherapy

Radiological Protection in Ion Beam Radiotherapy 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ICRP ref 4851-1931-9834 17 April 2014 Annals of the ICRP ICRP PUBLICATION 1XX Radiological Protection in Ion Beam Radiotherapy 16 17 18 19 20 21 22 23 24 25 26 27 28

More information

Large-area Two-Dimensional Thermoluminescence Dosimetry System in Ion Beam Quality Assurance

Large-area Two-Dimensional Thermoluminescence Dosimetry System in Ion Beam Quality Assurance Large-area Two-Dimensional Thermoluminescence Dosimetry System in Ion Beam Quality Assurance J. Gajewski1, M. Kłosowski1, S. Greilich2, P. Olko1 Institute of Nuclear Physics, Kraków, Poland German Cancer

More information

State-of-the-art proton therapy: The physicist s perspective

State-of-the-art proton therapy: The physicist s perspective State-of-the-art proton therapy: Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Overview of presentation 1. State-of-the-art proton delivery 2. Current challenges 3. New

More information

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam University of Chicago CDH Proton Center LET study C. Reft 1, H. Ramirez 2 and M. Pankuch

More information

Nuclear Physics in Proton Radiotherapy

Nuclear Physics in Proton Radiotherapy Nuclear Physics in Proton Radiotherapy Cynthia Keppel, PhD Thomas Jefferson National Accelerator Facility (Hampton University Proton Therapy institute) International Nuclear Physics Conference Adelaide,

More information

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER Bro. Dr. Collie Miller IARC/WHO Based on trends in the incidence of cancer, the International Agency for Research on Cancer (IARC) and WHO

More information

Road Map for the development of hadron therapy and associated nuclear medicine methods at JINR:

Road Map for the development of hadron therapy and associated nuclear medicine methods at JINR: НТС ОЭЗ, 07 октября 2011 Road Map for the development of hadron therapy and associated nuclear medicine methods at JINR: Development of 3D conformal Proton therapy Design of various devices for proton

More information

La ricerca e la terapia in adroterapia-2. R.Orecchia / P. Fossati

La ricerca e la terapia in adroterapia-2. R.Orecchia / P. Fossati La ricerca e la terapia in adroterapia-2 R.Orecchia / P. Fossati Dose (Gy) = energy (joule) / mass (kg) One degree of fever (from 37.5 to 38.5 ) > 4000 Gy RT small dose big damage Photons : Dose Resposne

More information

Research on Cancer Therapy with Carbon Beams Development of Human Friendly Cancer Therapy with Carbon Ion Beams

Research on Cancer Therapy with Carbon Beams Development of Human Friendly Cancer Therapy with Carbon Ion Beams Research on Cancer Therapy with Carbon Beams Development of Human Friendly Cancer Therapy with Carbon Ion Beams Tadashi Kamada, M.D., Ph.D. Director of Research Center for Charged Particle Therapy E-mail:

More information

Proton and helium beams: the present and the future of light ion beam therapy

Proton and helium beams: the present and the future of light ion beam therapy Proton and helium beams: the present and the future of light ion beam therapy Dr. Andrea Mairani Group Leader Biophysics in Particle Therapy Heidelberg Ion Beam Therapy Center HIT Department of Radiation

More information

Status of H 1 and C 12

Status of H 1 and C 12 Status of H 1 and C 12 Herman Suit No Conflict of Interest 1 Goal of a New Treatment Modality Tumor Control Probability or No in Complication Rate 2 Truism No Advantage to: any Patient for any Radiation

More information

FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017

FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017 FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE Geoffrey S. Ibbott, Ph.D. June 20, 2017 1 DISCLOSURES My institution holds Strategic Partnership Research Agreements with Varian, Elekta, and Philips

More information

PAMELA Particle Accelerator for MEdicaL Applications

PAMELA Particle Accelerator for MEdicaL Applications PAMELA Particle Accelerator for MEdicaL Applications Suzie Sheehy, DPhil candidate John Adams Institute for Accelerator Science Particle Physics, University of Oxford 1 Clinical Requirements Charged Particle

More information

A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe

A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe SEEIIST South East Europe International Institute for Sustainable Technologies A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe U. Amaldi a, J. Balosso b, M. Dosanjh

More information

Recent advances in dosimetry in reference conditions for proton and light-ion beams

Recent advances in dosimetry in reference conditions for proton and light-ion beams Recent advances in dosimetry in reference conditions for proton and light-ion beams S. Vatnitskiy a), P. Andreo b) and D.T.L. Jones c) a) MedAustron, Wiener Neustadt, Austria b) Medical Radiation Physics,

More information

Proton Beam Therapy at Mayo Clinic

Proton Beam Therapy at Mayo Clinic Proton Beam Therapy at Mayo Clinic Jon J. Kruse, Ph.D. Mayo Clinic Dept. of Radiation Oncology Rochester, MN History of Proton Therapy at Mayo 2002: Decided to consider particle therapy analysis and education

More information

Chapter 41 New Facilities: Plans and Proposals

Chapter 41 New Facilities: Plans and Proposals Chapter 41 New Facilities: Plans and Proposals Ramona Mayer and Stanislav Vatnitsky Abstract Ion beam facilities that have either become operational since 2001 or are at present under construction or in

More information

Hypofractionation in particle therapy. Marco Durante

Hypofractionation in particle therapy. Marco Durante Hypofractionation in particle therapy Marco Durante 29.04.2014 Radiosurgery (SBRT): the new frontier in stereotactic imageguided radiotherapy Stage I (T1N0M0) NSCLC Oligometastases Hepatocellular carcinoma

More information

Extending LEIR to provide ion-beams for bio-medical experiments

Extending LEIR to provide ion-beams for bio-medical experiments Extending LEIR to provide ion-beams for bio-medical experiments ICTR-PHE 2012 Daniel Abler CERN danielabler@cernch 27022012 Daniel Abler (CERN) Biomedical Facility at LEIR 27022012 1 / 17 Background: Action

More information

Hampton University Proton Therapy Institute

Hampton University Proton Therapy Institute Hampton University Proton Therapy Institute Brief introduction to proton therapy technology, its advances and Hampton University Proton Therapy Institute Vahagn Nazaryan, Ph.D. Executive Director, HUPTI

More information

8/1/2016. Motion Management for Proton Lung SBRT. Outline. Protons and motion. Protons and Motion. Proton lung SBRT Future directions

8/1/2016. Motion Management for Proton Lung SBRT. Outline. Protons and motion. Protons and Motion. Proton lung SBRT Future directions Motion Management for Proton Lung SBRT AAPM 2016 Outline Protons and Motion Dosimetric effects Remedies and mitigation techniques Proton lung SBRT Future directions Protons and motion Dosimetric perturbation

More information

Cancer: A Medical Challenge for Physics

Cancer: A Medical Challenge for Physics Cancer: A Medical Challenge for Physics Ken Peach Particle Therapy Cancer Research Institute (Oxford Martin School) & John Adams Institute for Accelerator Science, University of Oxford Lund, April 9 th

More information

Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience

Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience Stephanie E. Combs, MD Department of Radiation Oncology University of Heidelberg, Germany Carbon ion RT at GSI Active beam delivery

More information

Future dosimetry issues: protons, hadrons & MR linacs

Future dosimetry issues: protons, hadrons & MR linacs Future dosimetry issues: protons, hadrons & MR linacs Hugo Bouchard, PhD, MCCPM Senior Research Scientist Radiation dosimetry group National Physical Laboratory May 2014 Overview 1. Proton and hadron therapy

More information

Status of Proton Therapy: results and future trends

Status of Proton Therapy: results and future trends Status of Proton Therapy: results and future trends E. Pedroni Paul Scherrer Institute Division of Radiation Medicine CH-5232 Villigen PSI Abstract The number of centres investigating proton therapy in

More information

Nuclear Instruments and Methods in Physics Research A

Nuclear Instruments and Methods in Physics Research A Nuclear Instruments and Methods in Physics Research A 620 (2010) 563 577 Contents lists available at ScienceDirect Nuclear Instruments and Methods in Physics Research A journal homepage: www.elsevier.com/locate/nima

More information

2nd Joint Symposium 2011 on Carbon Ion Radiotherapy

2nd Joint Symposium 2011 on Carbon Ion Radiotherapy NIRS-M-243 Proceedings of NIRS-ETOILE 2nd Joint Symposium 2011 on Carbon Ion Radiotherapy Nov.25-27, 2011 Centre ETOILE, Lyon-France Organized by NIRS National Institute of Radiological Sciences, Japan

More information

Current Status and Future Medical Perspectives at MedAustron. U. Mock EBG MedAustron GmbH

Current Status and Future Medical Perspectives at MedAustron. U. Mock EBG MedAustron GmbH Current Status and Future Medical Perspectives at MedAustron U. Mock EBG MedAustron GmbH Cancer treatment facility Ion beam therapy with protons and carbon ions Research facility Medical physics Radiobiology

More information

H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen

H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen : Medical Operation of the 2 nd Machine, Production and Commissioning Status of Machines No. 3 to 7 H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen VARIAN Medical Systems Particle

More information

I. Equipments for external beam radiotherapy

I. Equipments for external beam radiotherapy I. Equipments for external beam radiotherapy 5 linear accelerators (LINACs): Varian TrueBeam 6, 10 & 18 MV photons, 6-18 MeV electrons, image-guided (IGRT) and intensity modulated radiotherapy (IMRT),

More information

along their path through the body damaging healthy cells as they go clinicians and

along their path through the body damaging healthy cells as they go clinicians and TECHNOLOGY FEATURE SHARP SHOOTERS Beams of charged particles can treat cancer more safely and effectively than X-rays. Physicists and biomedical researchers are working to refine the technology for wider

More information

Practical Challenges and Opportunities for Proton Beam Therapy. M. F. Moyers Loma Linda University Medical Center

Practical Challenges and Opportunities for Proton Beam Therapy. M. F. Moyers Loma Linda University Medical Center Practical Challenges and Opportunities for Proton Beam Therapy M. F. Moyers Loma Linda University Medical Center Outline I. Introduction II. Registration and Immobilization III. Beam Shaping IV. Localization

More information

BENEFITS Reduced side effects Better quality of life outcomes Minimal disruption to daily life Proven to be effective among all age groups

BENEFITS Reduced side effects Better quality of life outcomes Minimal disruption to daily life Proven to be effective among all age groups Quality Cancer Treatment in Resort Environment PROTON THERAPY BENEFITS Reduced side effects Better quality of life outcomes Minimal disruption to daily life Proven to be effective among all age groups

More information

UK X-FEL National Laboratory Perspective

UK X-FEL National Laboratory Perspective UK X-FEL National Laboratory Perspective Susan Smith STFC ASTeC IoP PAB/STFC Workshop Towards a UK XFEL 16 th February 2016 Content Overview STFC national labs capabilities FEL R&D Underpinning accelerator

More information

UK FEL R&D Plans Jim Clarke

UK FEL R&D Plans Jim Clarke UK FEL R&D Plans Jim Clarke STFC Daresbury Laboratory & The Cockcroft Institute IoP PAB/STFC Workshop Towards a UK XFEL 16 th February 2016 Contents UK Context & Selected FEL projects 4GLS ALICE NLS SwissFEL

More information

Radiobiology for particle therapy

Radiobiology for particle therapy Radiobiology for particle therapy Marco Durante CNAO-NIRS meeting, Pavia 21.03.2010 INFN Workshop, Napoli, 4.4.2014 2 The radiobiological adavantages of particle therapy Jakob et al., PNAS 2009 PIDE database

More information

Intensity Modulated RadioTherapy

Intensity Modulated RadioTherapy Intensity Modulated RadioTherapy A clinical application of a small accelerator University Medical Center Groningen A.A. van t Veld PhD I. Hoveijn PhD part 1 part2 CERN/KVI accelerator school, Zeegse, June

More information

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015) PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015) Course Description: This course is an introduction to physics in medicine and is intended to introduce

More information

Dr. Robert R. Wilson, a physicist who had worked on

Dr. Robert R. Wilson, a physicist who had worked on Radiation Therapy With Charged Particles Daniela Schulz-Ertner, MD,* Oliver Jäkel, PhD, and Wolfgang Schlegel, PhD Charged particle beams can offer an improved dose conformation to the target volume as

More information

TERA PROGRAMME: MEDICAL APPLICATIONS OF PROTONS AND IONS

TERA PROGRAMME: MEDICAL APPLICATIONS OF PROTONS AND IONS TERA PROGRAMME: MEDICAL APPLICATIONS OF PROTONS AND IONS Ugo Amaldi CERN, 1211-Geneva 23, Switzerland and TERA Foundation, Via Puccini 11, 28100-Novara, Italy Abstract The most recent applications of hadron

More information

Advances in external beam radiotherapy

Advances in external beam radiotherapy International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Michael Brada

More information

Present Status and Future Developments in Proton Therapy

Present Status and Future Developments in Proton Therapy Present Status and Future Developments in Proton Therapy Alfred R. Smith Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030,

More information

Planning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment

Planning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment Planning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment Barry W. Wessels, Ph.D. Director of Medical Physics and Dosimetry Case Western Reserve

More information

Applications of Particle Accelerators

Applications of Particle Accelerators Applications of Particle Accelerators Prof. Rob Edgecock STFC Rutherford Appleton Laboratory EMMA Accelerator at Daresbury Laboratory Applications >30000 accelerators in use world-wide: 44% for radiotherapy

More information